News

What Investors Can Expect from SL Green Realty's Earnings

What Investors Can Expect from SL Green Realty's Earnings

Insights into SL Green Realty's Financial Landscape

SL Green Realty (NYSE: SLG) is preparing to deliver its latest quarterly earnings, and investors are eager for the details. Analysts predict an earnings per share (EPS) of $1.24, which will be crucial in determining the company's future trajectory.

The anticipation surrounding this announcement is palpable as investors are keen to see if SL Green will exceed expectations and provide positive guidance for the upcoming quarter.

Past Earnings Performance

In the last quarter, SL Green managed to beat its EPS estimate by $0.45. However, this good news was met with a surprising 1.43% decline in the share price the following day. This highlights how market reactions can be unpredictable despite positive earnings reports.

Reviewing SL Green Realty's historical performance sheds light on the company's trends:

Analyst Insights

Staying informed is critical for investors, and SL Green has received 15 analyst ratings. The consensus opinion suggests a Neutral perspective, with an average one-year price target hovering around $60.60. This figure implies a possible downside of around 13.44%, indicating cautious sentiment among analysts regarding the company's performance.

Comparative Analysis with Peers

SL Green Realty operates in a competitive landscape. By examining key competitors like Kilroy Realty and Cousins Properties, we can glean valuable insights into market dynamics:

  • Kilroy Realty holds a Neutral rating from analysts, with an average price target of $38.67, suggesting a potential 44.77% downside.
  • Cousins Properties enjoys an Outperform consensus from analysts, with an average price target of $30.86, implying a more favorable outlook despite a potential 55.92% downside.
  • Highwoods Properties is rated Neutral, with a one-year price target of $32.50, indicating a possible 53.58% downside.

Essential Findings from Peer Analysis

The peer analysis encapsulates vital metrics that illuminate SL Green Realty's competitive standing in the industry:

CompanyConsensusRevenue GrowthGross ProfitReturn on Equity
SL Green RealtyNeutral-9.44%$113.02M-0.07%
Kilroy RealtyNeutral-1.25%$187.33M0.89%
Cousins PropsOutperform4.24%$142.34M0.18%
Highwoods PropsNeutral-1.23%$140.18M2.64%

Notably, SL Green Realty struggles in revenue growth and gross profit, with figures trailing behind those of its competitors. The company also reports the lowest return on equity, highlighting ongoing challenges in delivering satisfactory shareholder returns.

A Closer Look at SL Green Realty

As a major player in Manhattan's real estate market, SL Green Realty oversees approximately 32 million square feet of office space. The firm also maintains a select portfolio of retail properties, functioning as a real estate investment trust.

Financial Performance Breakdown

Market Capitalization: SL Green's market capitalization stands out in the industry, reflecting a dominant position among peers.

Revenue Trends: However, recent revenue metrics reveal a concerning decline of about -9.44%. This downturn puts SL Green at a disadvantage compared to its industry counterparts, highlighting significant challenges ahead.

Net Margin Insights: The company's net margin currently rests at -1.17%, suggesting difficulties in achieving profitability.

Return on Equity (ROE): SL Green's ROE is recorded at -0.07%, indicative of challenges in capital efficiency.

Return on Assets (ROA): Similarly, the ROA stands at -0.03%, signaling difficulties in optimizing asset utilization.

Debt Management Practices: On a positive note, SL Green maintains a balanced debt strategy, with a debt-to-equity ratio of 1.31, which is below industry averages.

Frequently Asked Questions

What is SL Green Realty's upcoming earnings forecast?

Analysts predict an earnings per share (EPS) of $1.24 for SL Green Realty's upcoming earnings report.

How has SL Green's stock performed after past earnings?

After the last earnings report, SL Green's stock price declined by 1.43%, despite beating EPS estimates.

What do analysts say about SL Green's stock rating?

The consensus among analysts is a Neutral rating with an average one-year price target of $60.60.

How does SL Green compare to its competitors?

SL Green ranks lower in revenue growth and gross profit compared to peers like Cousins Properties and Kilroy Realty.

What market position does SL Green Realty hold?

SL Green Realty is one of the largest property owners in Manhattan, managing significant office space and retail holdings.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 281

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 155

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 219

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 156

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 74

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 223

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 218

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 160

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading

Top 5 Most Recently Viewed Articles

R Systems Shines as a Major Contender in Engineering Services

Updated Category News Views 206

R Systems Acknowledged for Engineering Excellence R Systems International Limited, a leader in digital product engineering and technology solutions, has been recognized in the latest evaluation conducted by Everest Group. This prominent acknowledgment positions R Systems as a Major Contender in the ISV and Internet-specific SPES PEAK Matrix® Assessment for the year 2024....

Continue Reading
AppFolio Achieves Growth: Analysts Reaffirm $300 Target

Updated Category News Views 68

DA Davidson Affirms $300 Price Target for AppFolio Recently, DA Davidson reaffirmed its Buy rating for AppFolio (NASDAQ: APPF) and maintained a price target of $300. As a leading provider of cloud-based software solutions, AppFolio is recognized for its strategic growth initiatives. The firm highlighted the company's momentum ahead of its third-quarter earnings report and...

Continue Reading
Important Class Action Emerging for West Pharmaceutical Services Investors

Updated Category News Views 162

Class Action Overview for West Pharmaceutical Services, Inc. Levi & Korsinsky, LLP informs all investors in West Pharmaceutical Services, Inc. about a significant class action securities lawsuit arising from claims of securities fraud against the company. This announcement serves as an important notice to those who hold shares of West Pharmaceutical Services, Inc. (NYSE:...

Continue Reading
Zelluna's Upcoming Forum: Insight into Cancer Treatment Strategies

Updated Category News Views 190

Explore the Upcoming Investor Forum by Zelluna Zelluna (OSE: ZLNA), a trailblazer in the realm of allogeneic 'off the shelf' T Cell Receptor-based Natural Killer (TCR-NK) cells aimed at combating cancer, has announced an engaging Investor Science and Strategy Forum that offers a closer look at their innovative approaches. This notable event is set to take place in Oslo,...

Continue Reading
Challenges Facing Airlines Due to Economic Shifts and Strikes

Updated Category News Views 296

Understanding the Shift in Airline Operations As airlines adapt to changing economic conditions and demand patterns, many have begun scaling back their flight offerings to certain international markets. The situation is particularly pronounced with regards to flights to China, where reduced demand and rising operational costs have forced several airlines to reconsider...

Continue Reading